Fifth Third Bancorp’s Oncolytics Biotech ONCY Stock Holding History

Fifth Third Bancorp’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$57.1K	Buy	85,526 +40,000	+88%	+$32.5K	﹤0.01%	3209
2026 Q2	$43.2K	Buy	+45,526	New	+$42.2K	﹤0.01%	3281
2022 Q3	–	Sell	-1,000	Closed	-$1K	–	2718
2022 Q2	$1K	Sell	1,000 -10,000	-91%	-$12.2K	﹤0.01%	2558
2022 Q1	$17K	Buy	11,000 +10,000	+1,000%	+$16.8K	﹤0.01%	1879
2021 Q4	$1K	Hold	1,000	–	–	﹤0.01%	2627
2021 Q3	$2K	Hold	1,000	–	–	﹤0.01%	2482
2021 Q2	$3K	Hold	1,000	–	–	﹤0.01%	2300
2021 Q1	$4K	Hold	1,000	–	–	﹤0.01%	2228
2020 Q4	$2K	Hold	1,000	–	–	﹤0.01%	2236
2020 Q3	$2K	Hold	1,000	–	–	﹤0.01%	2064
2020 Q2	$2K	Hold	1,000	–	–	﹤0.01%	1981
2020 Q1	$1K	Buy	+1,000	New	+$2.5K	﹤0.01%	2058

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return

Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return

Fifth Third Bancorp's ONCY Position: Q3 2026 in Review

Fifth Third Bancorp increased its Oncolytics Biotech (ONCY) stake by 88% in Q3 2026, buying an estimated $32.5K and bringing the position to 85,526 shares worth $57.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3209.

Fifth Third Bancorp first reported a position in ONCY in Q1 2020 and has held it in 12 quarters since. 33 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

Fifth Third Bancorp held 85,526 shares of Oncolytics Biotech worth $57.1K as of Q3 2026.
Fifth Third Bancorp bought 40,000 Oncolytics Biotech shares in Q3 2026, an estimated $32.5K.
Oncolytics Biotech made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q3 2026, its #3209 holding.
Fifth Third Bancorp first reported a position in Oncolytics Biotech in Q1 2020 and has held it in 12 quarters since.
33 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on Fifth Third Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.